Po–Sung Chu

2.0k total citations · 1 hit paper
42 papers, 825 citations indexed

About

Po–Sung Chu is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Po–Sung Chu has authored 42 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 25 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Po–Sung Chu's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (11 papers) and Immune Cell Function and Interaction (9 papers). Po–Sung Chu is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (11 papers) and Immune Cell Function and Interaction (9 papers). Po–Sung Chu collaborates with scholars based in Japan, United States and Germany. Po–Sung Chu's co-authors include Takanori Kanai∥, Nobuhiro Nakamoto, Hirotoshi Ebinuma, Nobuhito Taniki, Yohei Mikami, Hidetsugu Saito, Toshifumi Hibi∥, Toshiaki Teratani, Keisuke Ojiro and Michiie Sakamoto and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Gastroenterology.

In The Last Decade

Po–Sung Chu

40 papers receiving 809 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells

2021 147 citations Yuzo Koda, Toshiaki Teratani et al. profile →

Peers

Po–Sung Chu

EPIDE

HEPAT

IMMUN

SURGE

Nirupma Trehanpati India

Ali Mencin United States

Anke Liepelt Germany

Gakuhei Son Japan

Benedikt Kaufmann Germany

Min Lian China

Kolade M. Agboola United States

Dekai Qiu China

Xiaogang Xiang China

Kenichiro Mikami Japan

Nirupma Trehanpati India

Po–Sung Chu

518 ×1.2

EPIDE

443 ×1.3

HEPAT

246 ×1.0

IMMUN

279 ×1.8

138 ×1.3

SURGE

Citations per year, relative to Po–Sung Chu Po–Sung Chu (= 1×) peers Nirupma Trehanpati

Countries citing papers authored by Po–Sung Chu

Since Specialization

Citations

This map shows the geographic impact of Po–Sung Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po–Sung Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po–Sung Chu more than expected).

Fields of papers citing papers by Po–Sung Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po–Sung Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po–Sung Chu. The network helps show where Po–Sung Chu may publish in the future.

Co-authorship network of co-authors of Po–Sung Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Po–Sung Chu. A scholar is included among the top collaborators of Po–Sung Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po–Sung Chu. Po–Sung Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ishigaki, Sho, Yasushi Kondo, Po–Sung Chu, et al.. (2023). Successful treatment of refractory enteritis and arthritis with combination of tumour necrosis factor and interleukin-6 inhibition in patients with ulcerative colitis. Modern Rheumatology Case Reports. 8(1). 33–36. 1 indexed citations

Chu, Po–Sung, Nobuhiro Nakamoto, Yuya Hagihara, et al.. (2023). Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis. iScience. 26(3). 106220–106220. 7 indexed citations

Chu, Po–Sung, Toshiaki Teratani, Yosuke Harada, et al.. (2023). IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis. JHEP Reports. 5(7). 100757–100757. 3 indexed citations

Sugimoto, Hisashi, Yôichi Ôshima, Yuki Oba, et al.. (2022). Successful Case of Deceased Donor Liver Transplant for Polycystic Liver Disease. Transplantation Proceedings. 54(10). 2779–2783. 3 indexed citations

Chu, Po–Sung, Yuzo Koda, Nobuhito Taniki, et al.. (2022). Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts. PLoS ONE. 17(10). e0276925–e0276925.

Koda, Yuzo, Nobuhiro Nakamoto, Po–Sung Chu, et al.. (2022). CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury. JCI Insight. 7(17). 5 indexed citations

Taniki, Nobuhito, Nobuhiro Nakamoto, Po–Sung Chu, et al.. (2022). Th17 cells in the liver: balancing autoimmunity and pathogen defense. Seminars in Immunopathology. 44(4). 509–526. 11 indexed citations

Chu, Po–Sung, Aya Yoshida, Nobuhito Taniki, et al.. (2021). Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis. PLoS ONE. 16(4). e0250062–e0250062. 4 indexed citations

Chu, Po–Sung, Aya Yoshida, Nobuhito Taniki, et al.. (2021). Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology. 20(11). 2641–2643.e3. 5 indexed citations

10.

Kashiwagi, Kazuhiro, Michiyo Takayama, Ryoko Shimizu‐Hirota, et al.. (2020). A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity. Clinical Nutrition ESPEN. 38. 86–93. 22 indexed citations

11.

Shiba, Shunsuke, Po–Sung Chu, Nobuhiro Nakamoto, et al.. (2020). Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study. BMC Gastroenterology. 20(1). 53–53. 6 indexed citations

12.

Chu, Po–Sung, Masahiro Shinoda, Taizo Hibi, et al.. (2020). Late-onset acute liver failure due to Wilson’s disease managed by plasmapheresis and hemodiafiltration successfully serving as a bridge for deceased donor liver transplantation: a case report and literature review. Clinical Journal of Gastroenterology. 13(6). 1239–1246. 6 indexed citations

13.

Morikawa, Rei, Nobuhiro Nakamoto, Po–Sung Chu, et al.. (2020). Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. Journal of Hepatology. 74(3). 511–521. 30 indexed citations

14.

Koda, Yuzo, Nobuhiro Nakamoto, Po–Sung Chu, et al.. (2019). Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35. Journal of Clinical Investigation. 129(8). 3201–3213. 29 indexed citations

15.

Chu, Po–Sung, Nobuhiro Nakamoto, Nobuhito Taniki, et al.. (2017). On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C. PLoS ONE. 12(6). e0179096–e0179096. 51 indexed citations

16.

Usui∥, Shingo, Hirotoshi Ebinuma, Po–Sung Chu, et al.. (2017). Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis. BMC Gastroenterology. 17(1). 106–106. 5 indexed citations

17.

Chu, Po–Sung, Hirotoshi Ebinuma, Nobuhiro Nakamoto, et al.. (2015). Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/ Ribavirin Therapy in Chronic Hepatitis C. PLoS ONE. 10(5). e0125664–e0125664. 2 indexed citations

18.

Sugiyama, Kazuo, Hirotoshi Ebinuma, Nobuhiro Nakamoto, et al.. (2014). Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus. PLoS ONE. 9(4). e94460–e94460. 37 indexed citations

19.

Kanai∥, Takanori, Yohei Mikami, Po–Sung Chu, et al.. (2013). IL-22-Producing RORγt-Dependent Innate Lymphoid Cells Play a Novel Protective Role in Murine Acute Hepatitis. PLoS ONE. 8(4). e62853–e62853. 30 indexed citations

20.

Nakamoto, Nobuhiro, Hirotoshi Ebinuma, Takanori Kanai∥, et al.. (2011). CCR9+ Macrophages Are Required for Acute Liver Inflammation in Mouse Models of Hepatitis. Gastroenterology. 142(2). 366–376. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact